Published in J Clin Microbiol on September 10, 2008
Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J Clin Microbiol (2010) 2.47
Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol (2010) 2.32
Comparison of a commercial multiplex real-time PCR to the cell cytotoxicity neutralization assay for diagnosis of clostridium difficile infections. J Clin Microbiol (2009) 1.67
Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty? J Mol Diagn (2011) 1.41
Evaluation of the C.Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of clostridium difficile disease. J Clin Microbiol (2010) 1.38
Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile. J Clin Microbiol (2009) 1.33
Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection. J Clin Microbiol (2010) 1.04
Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment. World J Gastroenterol (2013) 1.03
Surveillance for Clostridium difficile infection: ICD-9 coding has poor sensitivity compared to laboratory diagnosis in hospital patients, Singapore. PLoS One (2011) 0.97
Clinical and laboratory evaluation of a real-time PCR for Clostridium difficile toxin A and B genes. Eur J Clin Microbiol Infect Dis (2012) 0.89
Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The IMMINENT Study. Glob Adv Health Med (2014) 0.89
Frequency of abnormal fecal biomarkers in irritable bowel syndrome. Glob Adv Health Med (2014) 0.88
A multiplex, internally controlled real-time PCR assay for detection of toxigenic Clostridium difficile and identification of hypervirulent strain 027/ST-1. Eur J Clin Microbiol Infect Dis (2011) 0.87
Impact of clinical awareness and diagnostic tests on the underdiagnosis of Clostridium difficile infection. Eur J Clin Microbiol Infect Dis (2015) 0.84
Comparison of ImmunoCard Toxins A&B and the new semiautomated Vidas Clostridium difficile Toxin A&B tests for diagnosis of C. difficile infection. J Clin Microbiol (2010) 0.80
Prevalence and molecular epidemiology of Clostridium difficile infection in Thailand. New Microbes New Infect (2016) 0.79
Evaluation of a chromogenic culture medium for the detection of Clostridium difficile. Yonsei Med J (2014) 0.76
Surveillance of Clostridium difficile Infections: Results from a Six-Year Retrospective Study in Nine Hospitals of a North Italian Local Health Authority. Int J Environ Res Public Health (2017) 0.75
Comparison of GenomEra C. difficile and Xpert C. difficile as confirmatory tests in a multistep algorithm for diagnosis of Clostridium difficile infection. J Clin Microbiol (2014) 0.75
Diagnostic algorithm using a sensitive broth culture method for detection of Clostridium difficile toxin from stool samples. Can J Infect Dis Med Microbiol (2009) 0.75
A Diagnostic Algorithm for the Detection of Clostridium difficile-Associated Diarrhea. Balkan Med J (2016) 0.75
Detection of clostridium difficile antigen and toxin in stool specimens: Comparison of the C. difficile quik chek complete enzyme immunoassay and GeneXpert C. difficile polymerase chain reaction assay. Saudi J Gastroenterol (2017) 0.75
Cytotoxicity assay in antibiotic-associated colitis. J Infect Dis (1979) 4.39
Clostridium difficile--associated diarrhea. Clin Infect Dis (1998) 4.06
Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile-associated diarrhea in hospitalized patients. J Clin Microbiol (2005) 1.80
Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay. J Clin Microbiol (2007) 1.49
"Second-look" cytotoxicity: an evaluation of culture plus cytotoxin assay of Clostridium difficile isolates in the laboratory diagnosis of CDAD. J Hosp Infect (2001) 1.49
["Second look" at cytotoxin B of Clostridium difficile in the course of diarrhea associated with antibiotic therapy]. Pathol Biol (Paris) (1999) 1.03
Evaluation of two rapid immunochromatography tests for the detection of Clostridium difficile toxins. Dig Dis Sci (2007) 0.99
[Evaluation of four immunoenzymatic tests for detecting Clostridium difficile toxins A and B]. Pathol Biol (Paris) (2006) 0.88
[Usefulness of immunological detection of both toxin A and toxin B in stool samples for rapid diagnosis of Clostridium difficile-associated diarrhea]. Kansenshogaku Zasshi (2007) 0.88
Evaluation of two immunochromatographic tests (ImmunoCard Toxins A&B, Xpect C. difficile Toxin A&B) and PCR for the detection of Clostridium difficile toxins in faecal samples. J Infect (2007) 0.86
Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med (1992) 8.15
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group. N Engl J Med (1995) 3.04
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill (2008) 2.43
Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother (2001) 2.42
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect (2011) 2.38
Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1995) 2.14
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect (2009) 2.13
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob Agents Chemother (2007) 2.04
[Antimicrobial therapy in exacerbated chronic obstructive pulmonary disease]. Arch Bronconeumol (2002) 2.03
Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. Antimicrob Agents Chemother (2002) 2.00
Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study. Medicine (Baltimore) (2001) 2.00
Visceral leishmaniasis in immunocompromised hosts. Am J Med (1987) 1.99
Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann Intern Med (1989) 1.82
Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci. J Clin Microbiol (2000) 1.78
Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides. Antimicrob Agents Chemother (1994) 1.78
Multiply antibiotic-resistant Streptococcus pneumoniae recovered from Spanish hospitals (1988-1994): novel major clones of serotypes 14, 19F and 15F. Microbiology (1996) 1.69
Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med (1993) 1.69
Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study. Clin Microbiol Infect (2014) 1.61
Evaluation of the upgraded amplified Mycobacterium tuberculosis direct test (gen-probe) for direct detection of Mycobacterium tuberculosis in respiratory and non-respiratory specimens. Diagn Microbiol Infect Dis (2001) 1.60
Evaluation of the MB/BacT mycobacterium detection system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2000) 1.59
Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis. Clin Infect Dis (1998) 1.59
Klebsiella bacteremia: an analysis of 100 episodes. Rev Infect Dis (1985) 1.56
Thalidomide in patients with acquired immunodeficiency syndrome. Arch Intern Med (1992) 1.56
Bloodstream infections in patients with kidney disease: risk factors for poor outcome and mortality. J Hosp Infect (2013) 1.55
Yersinia enterocolitica Septicemia. Am J Clin Pathol (1980) 1.54
Candida infective endocarditis. Eur J Clin Microbiol Infect Dis (2008) 1.41
In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates. J Antimicrob Chemother (2001) 1.38
Metronidazole resistance in Clostridium difficile is heterogeneous. J Clin Microbiol (2008) 1.38
Role of universal 16S rRNA gene PCR and sequencing in diagnosis of prosthetic joint infection. J Clin Microbiol (2011) 1.37
A conservative procedure for the diagnosis of catheter-related infections. Arch Intern Med (1990) 1.36
Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis (1992) 1.34
[Use of antibiotics in exacerbated chronic obstructive pulmonary disease]. Aten Primaria (2001) 1.31
Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain. Antimicrob Agents Chemother (2007) 1.28
Infections in hairy-cell leukemia. Blood (1978) 1.26
Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Clin Infect Dis (2000) 1.23
Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients. Clin Microbiol Infect (2010) 1.23
Group-C beta-hemolytic streptococcal bacteremia. Diagn Microbiol Infect Dis (1992) 1.22
Infectious osteitis pubis. Urology (1978) 1.22
Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999. Antimicrob Agents Chemother (2001) 1.22
Group G streptococcal endocarditis. Am J Clin Pathol (1978) 1.22
Leuconostoc species as a cause of bacteremia: two case reports and a literature review. Eur J Clin Microbiol Infect Dis (1991) 1.17
Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure. Kidney Int (2000) 1.17
Rapid detection of toxigenic Clostridium difficile from stool samples by a nested PCR of toxin B gene. J Hosp Infect (1999) 1.17
Nasal carriage of S. aureus increases the risk of surgical site infection after major heart surgery. J Hosp Infect (2007) 1.17
Group A streptococcal bacteremia. A 10-year prospective study. Medicine (Baltimore) (1997) 1.16
In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates. Antimicrob Agents Chemother (1998) 1.15
Rhodococcus equi infection in transplant recipients: case report and review of the literature. Transplantation (1998) 1.14
Lemierre's disease: postanginal bacteremia and pulmonary involvement caused by Fusobacterium necrophorum. Rev Infect Dis (1989) 1.12
Group B Streptococcus: a cause of urinary tract infection in nonpregnant adults. Clin Infect Dis (1992) 1.11
Molecular analysis of relapse vs re-infection in HIV-positive patients suffering from recurrent Clostridium difficile associated diarrhoea. J Hosp Infect (2001) 1.11
Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin Microbiol Infect (2004) 1.09
Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation. Antimicrob Agents Chemother (2005) 1.09
Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics. The Spanish Surveillance Group for Respiratory Pathogens. J Antimicrob Chemother (2000) 1.09
Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia. Clin Microbiol Infect (2012) 1.09
Coccidioidal meningitis. An analysis of thirty-one cases and review of the literature. Medicine (Baltimore) (1981) 1.07
In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugs. Antimicrob Agents Chemother (2000) 1.06
Postsurgical mediastinitis: a case-control study. Clin Infect Dis (1997) 1.06
Extra-intestinal infections caused by Clostridium difficile. Clin Microbiol Infect (2001) 1.06
Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Spain: a multicentre prevalence study (2002). Clin Microbiol Infect (2007) 1.05
Listeriosis in patients infected with human immunodeficiency virus. Rev Infect Dis (1991) 1.05
In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole. Antimicrob Agents Chemother (2005) 1.03
Evidence of nosocomial Stenotrophomonas maltophilia cross-infection in a neonatology unit analyzed by three molecular typing methods. Infect Control Hosp Epidemiol (1999) 1.03
An improved protocol for pulsed-field gel electrophoresis typing of Clostridium difficile. J Med Microbiol (2005) 1.02
Feculent meningitis: polymicrobial meningitis in colorectal surgery. Diagn Microbiol Infect Dis (2000) 1.02
In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia. J Antimicrob Chemother (2007) 1.01
Hereditary torsion dystonia in gypsies. Adv Neurol (1988) 1.00
Bacillus cereus endogenous panophthalmitis. Arch Ophthalmol (1979) 1.00
Apoptotic cell death in renal injury: the rationale for intervention. Curr Drug Targets Immune Endocr Metabol Disord (2002) 1.00
Group B streptococcus bacteremia in nonpregnant adults. Arch Intern Med (1997) 0.99
Tsukamurella: a cause of catheter-related bloodstream infections. Eur J Clin Microbiol Infect Dis (2008) 0.99
BK virus in liver transplant recipients: a prospective study. Transplant Proc (2009) 0.99
High incidence of tuberculosis in renal patients. Eur J Clin Microbiol Infect Dis (1990) 0.99
Management of methicillin-resistant Staphylococcus aureus infections. Clin Microbiol Infect (2009) 0.99
Fluconazole resistance mechanisms in Candida krusei: the contribution of efflux-pumps. Med Mycol (2006) 0.98
[Intimal sarcoma of the pulmonary artery: a rare cause of pulmonary hypertension]. Arch Bronconeumol (2006) 0.98
Corynebacterium striatum: an undescribed agent of pacemaker-related endocarditis. Clin Infect Dis (1996) 0.97
Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital. Clin Microbiol Infect (2010) 0.97
Cutaneous mucormycosis in a heart transplant patient associated with a peripheral catheter. Eur J Clin Microbiol Infect Dis (1995) 0.97
Staphylococcus aureus carriage among participants at the 13th European Congress of Clinical Microbiology and Infectious Diseases. Eur J Clin Microbiol Infect Dis (2005) 0.97
The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem? Clin Microbiol Infect (2012) 0.96
Direct identification of pathogens from positive blood cultures using matrix-assisted laser desorption-ionization time-of-flight mass spectrometry. Clin Microbiol Infect (2013) 0.95
In vitro activity of new quinolones against Clostridium difficile. J Antimicrob Chemother (2001) 0.95
Characterization of Mycobacterium tuberculosis Beijing isolates from the Mediterranean area. BMC Microbiol (2010) 0.95
Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit. Int J Antimicrob Agents (2000) 0.95
Evolution of penicillin and erythromycin co-resistance in Streptococcus pneumoniae in Spain. Int J Antimicrob Agents (2003) 0.95
Infection of hickman catheter by Pseudomonas (formerly flavimonas) oryzihabitans traced to a synthetic bath sponge. J Clin Microbiol (2000) 0.94
[Epidemic outbreak of methicillin-resistant Staphylococcus aureus in a general hospital. Preliminary report]. Enferm Infecc Microbiol Clin (1991) 0.94